Literature DB >> 29061778

Anticancer Activity of Artemisinin and its Derivatives.

Silvia Slezakova1, Jana Ruda-Kucerova2.   

Abstract

Artemisinin is an extract from the plant Artemisia annua. With its semi-synthetic derivatives, they form a group of well-known and efficacious antimalarial drugs. Recent studies have documented the potential anticancer effect of artemisinin and its derivatives (ARTs). This review summarizes results of preclinical studies, documenting mechanisms of anticancer actions of ARTs and clinical studies focused mainly on efficacy, safety and dose-ranging of ARTs as anticancer chemotherapeutics. The main mechanisms of action of ARTs is the production of reactive oxygen species, inhibition of cell cycle in G0/G1 phase, induction of apoptosis and inhibition of angiogenesis. Safety studies have shown no evident toxicity and low incidence of adverse effects. ARTs potential to inhibit growth of solid tumours suggests their application in a neoadjuvant therapy. Dihydroartemisinin and artesunate exhibit chemosensitising effects in vivo in breast, lung, pancreas and glioma cancer cells, proposing the use of ARTs also in combination anticancer therapy. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Artemisinin; Artesunate; anticancer activity; dihydroartemisinin; review

Mesh:

Substances:

Year:  2017        PMID: 29061778     DOI: 10.21873/anticanres.12046

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  41 in total

1.  Artemisitene suppresses tumorigenesis by inducing DNA damage through deregulating c-Myc-topoisomerase pathway.

Authors:  Jian Chen; Wenjuan Li; Ke Cui; Kaiyuan Ji; Shuxiang Xu; Yang Xu
Journal:  Oncogene       Date:  2018-05-24       Impact factor: 9.867

2.  Artesunate inhibits melanoma progression in vitro via suppressing STAT3 signaling pathway.

Authors:  Mehmet Berköz; Ferbal Özkan-Yılmaz; Arzu Özlüer-Hunt; Mirosław Krośniak; Ömer Türkmen; Duygu Korkmaz; Sıddık Keskin
Journal:  Pharmacol Rep       Date:  2021-02-20       Impact factor: 3.024

3.  Artesunate induces ER-derived-ROS-mediated cell death by disrupting labile iron pool and iron redistribution in hepatocellular carcinoma cells.

Authors:  Zhongyong Jiang; Ziwen Wang; Long Chen; Chi Zhang; Fengying Liao; Yawei Wang; Yang Wang; Peng Luo; Min Luo; Chunmeng Shi
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

4.  Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.

Authors:  Yulin Ren; A Douglas Kinghorn
Journal:  J Med Chem       Date:  2020-12-08       Impact factor: 7.446

Review 5.  Perspectives and controversies regarding the use of natural products for the treatment of lung cancer.

Authors:  Tingting Wen; Lei Song; Shucheng Hua
Journal:  Cancer Med       Date:  2021-03-02       Impact factor: 4.452

Review 6.  Emerging agents that target signaling pathways in cancer stem cells.

Authors:  Yue Yang; Xiaoman Li; Ting Wang; Qianqian Guo; Tao Xi; Lufeng Zheng
Journal:  J Hematol Oncol       Date:  2020-05-26       Impact factor: 17.388

7.  Corylin Suppresses Hepatocellular Carcinoma Progression via the Inhibition of Epithelial-Mesenchymal Transition, Mediated by Long Noncoding RNA GAS5.

Authors:  Chi-Yuan Chen; Chin-Chuan Chen; Tzong-Ming Shieh; Chuen Hsueh; Shu-Huei Wang; Yann-Lii Leu; Jang-Hau Lian; Tong-Hong Wang
Journal:  Int J Mol Sci       Date:  2018-01-27       Impact factor: 5.923

Review 8.  Biotechnological approaches for artemisinin production in Artemisia.

Authors:  Waqas Khan Kayani; Bushra Hafeez Kiani; Erum Dilshad; Bushra Mirza
Journal:  World J Microbiol Biotechnol       Date:  2018-03-27       Impact factor: 3.312

9.  Corylin increases the sensitivity of hepatocellular carcinoma cells to chemotherapy through long noncoding RNA RAD51-AS1-mediated inhibition of DNA repair.

Authors:  Chin-Chuan Chen; Chi-Yuan Chen; Shir-Hwa Ueng; Chuen Hsueh; Chau-Ting Yeh; Jar-Yi Ho; Li-Fang Chou; Tong-Hong Wang
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

Review 10.  Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy.

Authors:  Sankhadip Bose; Sabyasachi Banerjee; Arijit Mondal; Utsab Chakraborty; Joshua Pumarol; Courtney R Croley; Anupam Bishayee
Journal:  Cells       Date:  2020-06-11       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.